Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta - PubMed (original) (raw)
. 2005 Sep 2;280(35):31085-90.
doi: 10.1074/jbc.M502406200. Epub 2005 Jun 29.
Affiliations
- PMID: 15987688
- DOI: 10.1074/jbc.M502406200
Free article
Peptide blockers of the inhibition of neuronal nicotinic acetylcholine receptors by amyloid beta
Margaret H Magdesian et al. J Biol Chem. 2005.
Free article
Abstract
Alzheimer disease (AD) is characterized by accumulation of the neurotoxic amyloid beta peptide (Abeta) and by the loss of cholinergic neurons and nicotinic acetylcholine receptors (nAChRs) throughout the brain. Direct inhibition of nAChRs by Abeta has also been suggested to contribute to cholinergic dysfunction in AD. In an effort to find ligands capable of blocking Abeta-induced inhibition of nAChRs, we have screened a phage display library to identify peptides that bind to Abeta. Using this approach, we identified a heptapeptide denoted IQ, which binds with nanomolar affinity to Abeta and is homologous to the acetylcholine-binding protein and to most subtypes of nAChRs. Rapid kinetic whole-cell current-recording measurements showed that Abeta inhibits nAChR function in a dose-dependent manner in neuronal differentiated PC12 cells and that nanomolar concentrations of IQ completely block the inhibition by Abeta. These results indicate that the Abeta binding site in nAChRs is homologous to the IQ peptide and that this is a relevant target for Abeta neurotoxicity in AD and, more generally, for the regulation of nAChR function by soluble Abeta in a physiological context. Furthermore, the results suggest that the IQ peptide may be a lead for the development of novel drugs to block the inhibition of nAChRs in AD.
Similar articles
- Rescue of amyloid-Beta-induced inhibition of nicotinic acetylcholine receptors by a peptide homologous to the nicotine binding domain of the alpha 7 subtype.
Nery AA, Magdesian MH, Trujillo CA, Sathler LB, Juliano MA, Juliano L, Ulrich H, Ferreira ST. Nery AA, et al. PLoS One. 2013 Jul 22;8(7):e67194. doi: 10.1371/journal.pone.0067194. Print 2013. PLoS One. 2013. PMID: 23894286 Free PMC article. - Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Lilja AM, Porras O, Storelli E, Nordberg A, Marutle A. Lilja AM, et al. J Alzheimers Dis. 2011;23(2):335-47. doi: 10.3233/JAD-2010-101242. J Alzheimers Dis. 2011. PMID: 21116052 - beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice.
Pettit DL, Shao Z, Yakel JL. Pettit DL, et al. J Neurosci. 2001 Jan 1;21(1):RC120. doi: 10.1523/JNEUROSCI.21-01-j0003.2001. J Neurosci. 2001. PMID: 11150356 Free PMC article. - Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment.
Lombardo S, Maskos U. Lombardo S, et al. Neuropharmacology. 2015 Sep;96(Pt B):255-62. doi: 10.1016/j.neuropharm.2014.11.018. Epub 2014 Dec 13. Neuropharmacology. 2015. PMID: 25514383 Review. - Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity.
Liu Q, Wu J. Liu Q, et al. Acta Pharmacol Sin. 2006 Oct;27(10):1277-86. doi: 10.1111/j.1745-7254.2006.00430.x. Acta Pharmacol Sin. 2006. PMID: 17007734 Review.
Cited by
- Nicotinic receptors, amyloid-beta, and synaptic failure in Alzheimer's disease.
Jürgensen S, Ferreira ST. Jürgensen S, et al. J Mol Neurosci. 2010 Jan;40(1-2):221-9. doi: 10.1007/s12031-009-9237-0. Epub 2009 Aug 19. J Mol Neurosci. 2010. PMID: 19690986 Review. - Aβ oligomer-induced synapse degeneration in Alzheimer's disease.
Wilcox KC, Lacor PN, Pitt J, Klein WL. Wilcox KC, et al. Cell Mol Neurobiol. 2011 Aug;31(6):939-48. doi: 10.1007/s10571-011-9691-4. Epub 2011 May 3. Cell Mol Neurobiol. 2011. PMID: 21538118 Free PMC article. Review. - Phage display derived peptides for Alzheimer's disease therapy and diagnosis.
Zhang X, Zhang X, Gao H, Qing G. Zhang X, et al. Theranostics. 2022 Jan 31;12(5):2041-2062. doi: 10.7150/thno.68636. eCollection 2022. Theranostics. 2022. PMID: 35265198 Free PMC article. Review. - Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training.
De Sousa RAL, Improta-Caria AC. De Sousa RAL, et al. Metab Brain Dis. 2022 Mar;37(3):559-580. doi: 10.1007/s11011-022-00903-y. Epub 2022 Jan 25. Metab Brain Dis. 2022. PMID: 35075500 Review. - Lavandula angustifolia extract improves deteriorated synaptic plasticity in an animal model of Alzheimer's disease.
Soheili M, Tavirani MR, Salami M. Soheili M, et al. Iran J Basic Med Sci. 2015 Nov;18(11):1147-52. Iran J Basic Med Sci. 2015. PMID: 26949505 Free PMC article.